Search Results - Habucky, Karen

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Optimizing Commercial Manufacturing of Tisagenlecleucel for Patients in the US: A 4-Year Experiential Journey

    Optimizing Commercial Manufacturing of Tisagenlecleucel for Patients in the US: A 4-Year Experiential Journey by Rodrigues, Margarida, Duran, Emmanuel, Eschgfaeller, Bernd, Kuzan, David, Habucky, Karen

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation

    Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation by Ritchie, Ellen K, Latremouille-Viau, Dominick, Guerin, Annie, Pivneva, Irina, Habucky, Karen, Ndife, Briana, Joseph, George J, Atallah, Ehab

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As First-Line Therapy in the United States

    Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As... by Seiter, Karen, Latremouille-Viau, Dominick, Guerin, Annie, Ndife, Briana, Habucky, Karen, Joseph, George J, Pivneva, Irina, Gagnon-Sanschagrin, Patrick, Tang, Derek H

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States

    Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States by Seiter, Karen, Latremouille-Viau, Dominick, Guerin, Annie, Ndife, Briana, Habucky, Karen, Tang, Derek H., Pivneva, Irina, Gagnon-Sanschagrin, Patrick, Joseph, George J.

    Published in Advances in therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective

    Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective by Ritchie, Ellen K., Latremouille-Viau, Dominick, Guerin, Annie, Pivneva, Irina, Habucky, Karen, Ndife, Briana, Joseph, George J., Atallah, Ehab L.

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

    Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Ni... by Ritchie, Ellen K, Catchatourian, Rosalind, Klisovic, Rebecca B., Pinilla-Ibarz, Javier, Deininger, Michael W., Erba, Harry P., Radich, Jerald P., Savona, Michael R., Dautaj, Ilva, Purkayastha, Das, Habucky, Karen, Mauro, Michael J.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies

    Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving... by Nikiforow, Sarah, Frigault, Matthew J., Frey, Noelle V., Gardner, Rebecca A., Komanduri, Krishna V., Perales, Miguel-Angel, Kebriaei, Partow, Warkentin, Phyllis Irene, Pasquini, Marcelo, Aho, Joy Lynn, Levine, Bruce L., Heslop, Helen E., Hlucky, Tracey L., Habucky, Karen, Gharibo, Mecide, Jagasia, Madan, Locke, Frederick L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Cyclosporin pharmacokinetics in paediatric transplant recipients

    Cyclosporin pharmacokinetics in paediatric transplant recipients by COONEY, G. F, HABUCKY, K, HOPPU, K

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: